Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction

Cardiovascular Research

Volumn 80, Issue 2, 2008, Pages 209-218

  Palpant, Nathan J ^a   Day, Sharlene M ^a   Herron, Todd J ^a   Converso, Kimber L ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Ageing; Cardiac function; Hypoxia; Troponin I

Indexed keywords

CALCIUM; HISTIDINE; TROPONIN I;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HYPOXIA; MOUSE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; SYSTOLE; TRANSGENIC MOUSE;

AGE FACTORS; AGING; AMINO ACID SUBSTITUTION; ANIMALS; ANOXIA; CALCIUM SIGNALING; ECHOCARDIOGRAPHY, DOPPLER; HISTIDINE; HYDROGEN-ION CONCENTRATION; MICE; MICE, TRANSGENIC; MICROFILAMENTS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHORYLATION; STROKE VOLUME; TROPONIN I; VENTRICULAR DYSFUNCTION; VENTRICULAR PRESSURE;

EID: 54149115154     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn198     Document Type: Article

References (37)

1. Michaud CM, Murray CJL, Bloom BR. Burden of disease-implications for future research. JAMA 2001;285:535-539.
2. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
3. Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. J Appl Physiol 2007;103:2120-2128.
4. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-497.
5. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-354.
6. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003;107:139-146.
7. Deedwania PC. The key to unraveling the mystery of mortality in heart failure - an integrated approach. Circulation 2003;107:1719-1721.
8. 2+ regulatory sites of skeletal and cardiac troponin C in skinned muscle fibres. J Muscle Res Cell Motil 1997;18:599-609.
9. 2+ activation. Biochemistry 1994;33:8464-8471.
10. Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J 1995;9:755-767.
11. 2+-saturated form. Nature 2003;424:35-41.
12. 2+ sensitivity of tension in adult cardiac myocytes. Biophys J 2001;80:356A-356A.
13. 2+-regulated actomyosin S1 ATPase. J Biol Chem 2002;277:34662-34665.
14. 2+ and pH sensitivity. J Mol Cell Cardiol 2007;43:107-118.
15. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, La Cross NC et al. Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 2006;12:181-189.
16. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 2004;94:146-158.
17. 2+-independent mechanical tone and acute myocyte remodeling. Circ Res 2007;100:1494-1502.
18. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL et al. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 1999;104:469-481.
19. Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ Res 2004;94:1235-1241.
20. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002;34:951-969.
21. Koretsune Y, Marban E. Cell calcium in the patho-physiology of ventricular-fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction. Circulation 1989;80:369-379.
22. Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol 2002;132:699-721.
23. Lee JA, Allen DG. Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium. J Clin Invest 1991;88:361- 367.
24. Wehrens XHT, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005;67:69-98.
25. Kranias EG, Bers DM. Calcium and cardiomyopathies. Subcell Biochem 2007;45:523-537.
26. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol 1997;92(Suppl. 1):87-93.
27. del Monte F, Hajjar RJ, Harding SE. Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res 2001;88:E66-E67.
28. 2+, pH and the regulation of cardiac myofilament force and ATPase activity. Mol Cell Biochem 1989;89:163-167.
29. Westfall MV, Metzger JM. Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction. News Physiol Sci 2001;16:278-281.
30. 2+-activated myofilament tension in adult cardiac myocytes. Circ Res 2000;86:470-477.
31. Westfall MV, Rust EM, Metzger JM. Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc Natl Acad Sci USA 1997;94:5444-5449.
32. Urboniene D, Dias FAL, Pena JR, Walker LA, Solaro RJ, Wolska BM. Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res 2005;97:70-77.
33. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
34. Hunter WC. Role of myofilaments and calcium handling in left ventricular relaxation. Cardiol Clin 2000;18:443-457.
35. 2+, pHi, and contractility during ischemia and reperfusion. Circulation 1992;86(Suppl. 5):II371-II376.
36. 2+ transport system of myocardium in ageing. Gerontology 1988;34:64-74.
37. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-2849.